Clinical Trial Update: Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

This document reports the completion and posted results of a Phase 2 trial evaluating gemcitabine plus docetaxel in metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Docetaxel (Taxotere) (docetaxel)
• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-06-06